TrialClinical and experimental hypertension (New York, N.Y. : 1993)2010

Clinical and pharmacotherapeutic relevance of the double-chain domain of the angiotensin II type 1 receptor blocker olmesartan.

Yoshihiro Kiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.